Skip to main content
Contact Us
Subscribe
E-Edition
53°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Harmony Biosciences Holdings Inc
(NQ:
HRMY
)
35.23
+0.56 (+1.62%)
Streaming Delayed Price
Updated: 3:57 PM EST, Dec 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Harmony Biosciences Holdings Inc
< Previous
1
2
3
4
5
6
7
Next >
NASDAQ:HRMY stands out as a growth opportunity that won't break the bank.
January 10, 2024
Looking for growth without the hefty price tag? Consider NASDAQ:HRMY.
Via
Chartmill
Investors should take notice of NASDAQ:HRMY—it offers a great deal for the fundamentals it presents.
January 03, 2024
Don't overlook HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY)—it's a hidden gem with strong fundamentals and an attractive price tag.
Via
Chartmill
Why Harmony Biosciences Stock Got Slammed Today
January 02, 2024
The commercial-stage company was dinged by a bearish new take from a researcher.
Via
The Motley Fool
A Glimpse Into The Expert Outlook On Harmony Biosciences Through 6 Analysts
January 02, 2024
Via
Benzinga
2023 Year In Review
January 02, 2024
The S&P 500 had a strong year in 2023, returning about 24% to investors from the beginning of the year to the end. Some of that was a bounce back from a poor 2022 when it was down over 11%.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
NASDAQ:HRMY is showing good growth, while it is not too expensive.
December 18, 2023
HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) stands out as a growth opportunity that won't break the bank.
Via
Chartmill
Harmony Biosciences's Earnings Outlook
October 30, 2023
Via
Benzinga
Analyst Ratings for Harmony Biosciences
October 16, 2023
Via
Benzinga
In the world of growth stocks, NASDAQ:HRMY shines as a value proposition.
October 12, 2023
NASDAQ:HRMY, a growth stock which is not overvalued.
Via
Chartmill
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
December 17, 2023
While the broader healthcare sector offers myriad opportunities, these undervalued biotech picks could offer robust upside.
Via
InvestorPlace
NASDAQ:HRMY, an undervalued stock with good fundamentals.
December 13, 2023
When you look at HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
Via
Chartmill
Russell 2000 Front-Runners: 3 Stocks to Keep an Eye On
December 07, 2023
Although Russell 2000 stocks may operate in the lightweight category, these entities could potentially provide a knockout punch.
Via
InvestorPlace
Looking for growth without the hefty price tag? Consider NASDAQ:HRMY.
November 27, 2023
Investors seeking growth at a reasonable cost should explore HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY).
Via
Chartmill
NASDAQ:HRMY is probably undervalued for the fundamentals it is displaying.
November 22, 2023
HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via
Chartmill
While growth is established for NASDAQ:HRMY, the stock's valuation remains reasonable.
November 03, 2023
Investors should take note ofHARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY), a growth stock that remains attractively priced.
Via
Chartmill
Quick Look At Reports From ServiceNow, Chipotle, And Harmony
November 02, 2023
ServiceNow is a steady, reliable SaaS firm that continues to prove its value and growth potential to investors.
Via
Talk Markets
NASDAQ:HRMY is an undervalued gem with solid fundamentals.
November 01, 2023
For those who appreciate value investing, HARMONY BIOSCIENCES HOLDINGS (NASDAQ:HRMY) is a compelling option with its solid fundamentals.
Via
Chartmill
Harmony Biosciences (HRMY) Q3 2023 Earnings Call Transcript
October 31, 2023
HRMY earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday
October 31, 2023
U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 31, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results
October 31, 2023
From
Harmony Biosciences
Via
GlobeNewswire
Why Harmony Biosciences Stock Is Trading Higher Today
October 16, 2023
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) shares are trading higher on Monday as the stock rebounds after falling Friday on Phase 3 INTU
Via
Benzinga
Nasdaq Down Over 1%; Wells Fargo Beats Expectations
October 13, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 1% on Friday. The Dow traded down 0.02% to 33,622.97 while the NASDAQ fell 1.27% to 13,401.56. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
October 13, 2023
Via
Benzinga
Stocks Mixed Amid Earnings, Consumer Sentiment Data
October 13, 2023
Stocks are mixed this afternoon, as investors unpack earnings reports from several bank giants as well as economic data.
Via
Talk Markets
Why Shares of Harmony Bioscience Are Falling on Friday
October 13, 2023
The company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia.
Via
The Motley Fool
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
October 13, 2023
Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.
Via
Benzinga
Crude Oil Rises Sharply; Citigroup Posts Upbeat Earnings
October 13, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Friday. The Dow traded down 0.05% to 33,615.27 while the NASDAQ fell 1.22% to 13,409.29. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Sleep Disorder Related Harmony Biosciences Stock Trading Lower Today?
October 13, 2023
Harmony Biosciences Holdings Inc (NASDAQ: HRMY) announced topline results from the INTUNE Phase 3 study of pitolisant in patients with idiopathic hypersomnia (IH).
Via
Benzinga
New Possibilities For Cannabinoid Treatments: Acquisition To Transform Neuropsychiatric Disorder Therapies
October 11, 2023
Healthcare company Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) completed its previously announced acquisition of Zynerba Pharmaceuticals, Inc.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.